InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- AGM Shareholder Presentation 5 Nov 2020 4:09PM $0.113 $0.230 risen by 104.44%
- Appendix 4C and Quarterly Update 29 Oct 2020 9:02AM $0.125 $0.230 risen by 84%
- Appendix 2A & s708 notice (exercise of employee options) 21 Oct 2020 8:16AM $0.135 $0.230 risen by 70.37%
- Appendix 3G 21 Oct 2020 8:16AM $0.135 $0.230 risen by 70.37%
- Appendix 2A & s708 notice 12 Oct 2020 2:08PM $0.130 $0.230 risen by 76.92%
- Notice of Annual General Meeting/Proxy Form 2 Oct 2020 4:23PM $0.125 $0.230 risen by 84%
- ONJCRI Evaluates Monepantel Anti-Cancer Mechanism 29 Sep 2020 9:50AM $0.125 $0.230 risen by 84%
- Clarification statement 28 Sep 2020 11:17AM $0.130 $0.230 risen by 76.92%
- PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 Test 24 Sep 2020 9:07AM $0.125 $0.230 risen by 84%
- PAA awarded grant for Phase I trial in Motor Neurone Disease 21 Sep 2020 8:55AM $0.125 $0.230 risen by 84%
- Appendix 4G & Corporate Governance Statement 18 Sep 2020 6:03PM $0.125 $0.230 risen by 84%
- Annual Report 18 Sep 2020 6:02PM $0.125 $0.230 risen by 84%
- PharmAust Shareholder Update 14 Sep 2020 9:35AM $0.135 $0.230 risen by 70.37%
- Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed 9 Sep 2020 9:25AM $0.190 $0.230 risen by 21.05%
- Elanco Option Update 9 Sep 2020 9:23AM $0.190 $0.230 risen by 21.05%
- Trading Halt 7 Sep 2020 9:52AM $0.190 $0.230 risen by 21.05%
- Epichem in partnership to develop waste into fuel technology 1 Sep 2020 8:07AM $0.185 $0.230 risen by 24.32%
- Appendix 2A & s708 notice (exercise of employee options) 31 Aug 2020 6:35PM $0.185 $0.230 risen by 24.32%
- Appendix 4E & Preliminary Final Report 31 Aug 2020 12:12PM $0.200 $0.230 risen by 15%
- Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells 25 Aug 2020 9:35AM $0.235 $0.230 fallen by 2.13%
- Appendix 2A & s708 notice (exercise of staff options) 7 Aug 2020 4:54PM $0.195 $0.230 risen by 17.95%
- Appendix 2A & s708 notice (exercise of staff options) 31 Jul 2020 2:28PM $0.185 $0.230 risen by 24.32%
- Appendix 4C and Quarterly Update 28 Jul 2020 10:05AM $0.180 $0.230 risen by 27.78%
- Appendix 2A & s708 notice (exercise of options) 24 Jul 2020 3:30PM $0.190 $0.230 risen by 21.05%
- Appendix 2A & s708 notice (exercise of options) 17 Jul 2020 5:58PM n/a $0.230 n/a

326 - 350 of 796 results

Page 14 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.